Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Understand how volatile markets indices signal quick trends and what to watch for when assessing risk and opportunity in real time.
23,391 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
A cross-chain protocol says purchased tokens on Robinhood Chain vanished from users’ wallets, with losses tied to sus...
Retirees face roughly $36,000 per year in aging-in-place costs, rising faster than Social Security. A carefully craft...
Federal bank regulators issued joint guidance to remind lenders to assess credit risk when borrowers lack work author...
Bitcoin pushes toward 65K as inflation cools, and Pi Network’s PI shows a robust rebound, highlighting divergent move...
Morgan Stanley's latest bottom up view argues that AI infrastructure demand will outpace supply, turning the Nebius s...
A floated plan to require annual testosterone screening for service members 30 and older could reshape military healt...
Amazon announced a 2027 rollout of its Leo satellite internet in South Africa, teaming with Herotel to push into Afri...
TSMC delivers a record quarterly print as AI-driven demand powers growth. Margin expands and 2026 guidance rises, sig...
A 66-year-old with only $10k saved confronts retirement math as housing costs loom. Experts say disciplined saving, d...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...